Testing tenofovir for Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease at an early stage (Hoehn and Yahr scale 1 to 2.5).
- Your thinking and memory are good (MMSE score of 24 or more).
- You do not have other major brain conditions like essential tremor, stroke, or epilepsy.
- You have not had brain surgery for Parkinson's, such as deep brain stimulation.
- You are under 65 years old and not pregnant or breastfeeding.
- You do not have serious health problems like advanced heart, liver, or kidney disease, or an active infection like hepatitis B or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
This trial tests an experimental oral drug called GT-02287 for people with early-stage Parkinson's disease. The study aims to see if the drug can slow progression by targeting a protein linked to Parkinson's, and participants must be willing to have genetic testing and a spinal tap to check for that protein marker.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This study tests an investigational drug called LBT-3627 to see if it is safe and how the body processes it. It includes healthy volunteers and people with Parkinson's disease, and may help determine if the drug could be a future treatment.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.